| 1 |
Lyon AR， López-Fernández T， Couch LS， et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association （EHA）， the European Society for Therapeutic Radiology and Oncology （ESTRO） and the International Cardio-Oncology Society （IC-OS） ［J］. Eur Heart J， 2022， 43（41）: 4229-4361.
|
| 2 |
Cozma A， Sporis ND， Lazar AL， et al. Cardiac toxicity associated with immune checkpoint inhibitors: a systematic review［J］. Int J Mol Sci，2022 23（18）: 10948.
|
| 3 |
Herrmann J. From trends to transformation: where cardio-oncology is to make a difference ［J］. Eur Heart J， 2019， 40（48）: 3898-3900.
|
| 4 |
Sturgeon KM， Deng L， Bluethmann SM， et al. A population-based study of cardiovascular disease mortality risk in US cancer patients ［J］.Eur Heart J， 2019， 40（48）: 3889-3897.
|
| 5 |
谭雪莹， 张晶， 任卫东， 等.斑点追踪技术监测低剂量蒽环类药物对乳腺癌新辅助化疗患者的心脏毒性 ［J/OL］.中华医学超声杂志（电子版）， 2021， 18（2）: 143-149.
|
| 6 |
杨梦犀， 徐文婷， 戴全， 等.放疗相关心血管损伤的影像学表现与研究进展 ［J］. 临床心血管病杂志， 2024， 40（8）: 681-688.
|
| 7 |
智光. 超声心动图对肿瘤化疗中心脏功能的监测 ［J/CD］. 中华医学超声杂志（电子版）， 2018， 15（6）: 404-408.
|
| 8 |
Wouters KA， Kremer LC， Miller TL， et al. Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies ［J］. Br J Haematol， 2005， 131（5）: 561-578.
|
| 9 |
Lin X， Wu G， Wang S， et al. Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity ［J］. Front Pharmacol， 2023， 14:1255158.
|
| 10 |
Madan R， Benson R， Sharma DN， et al. Radiation induced heart disease: Pathogenesis， management and review literature ［J］. J Egypt Natl Canc Inst， 2015， 27（4）: 187-193.
|
| 11 |
陈静， 于绍梅， 何佳林. 孕妇纵隔B细胞源性非霍奇金淋巴瘤一例［J/OL］.中华医学超声杂志（电子版）， 2020， 17（9）: 920-921.
|
| 12 |
林荫光， 苏鹃， 覃秋， 等. 乳腺癌术后放疗治疗技术在危及器官防护效果中的应用 ［J］. 中国医疗设备， 2024， 39（7）: 147-152，163.
|
| 13 |
丛姗姗， 高艺花. 超声心动图评估放射治疗对左心室功能的影响［J］. 医学影像学杂志， 2021， 31（9）: 1593-1596.
|
| 14 |
Laufer-Perl M， Arias O， Dorfman SS， et al. Left atrial strain changes in patients with breast cancer during anthracycline therapy ［J］. Int J Cardiol， 2021， 330: 238-244.
|
| 15 |
Yi P， Li H， Su J， et al. Trastuzumab aggravates radiation induced cardiotoxicity in mice ［J］. Am J Cancer Res， 2022， 12（1）: 381-395.
|
| 16 |
Romanelli R， Ciampelli L， Mungai V. Severe heart disease induced by radiation and chemotherapy for Hodgkin's disease ［J］. Tumori， 1981，67（4）: 361-365.
|
| 17 |
Cottin Y， L'Huillier I， Casasnovas O， et al. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity ［J］. Eur J Echocardiogr， 2000， 1（3）: 180-183.
|
| 18 |
梁梦婕， 金怡， 郑哲岚. 超声二维斑点追踪技术在蒽环类化疗药物心脏毒性监测中的应用价值 ［J/CD］. 中华医学超声杂志（电子版），2019， 16（10）: 749-755.
|
| 19 |
Dobson R， Ghosh AK， Ky B， et al. BSE and BCOS guideline for transthoracic echocardiographic assessment of adult cancer patients receiving anthracyclines and/or trastuzumab ［J］. JACC CardioOncol，2021， 3（1）: 1-16.
|
| 20 |
Neilan TG， Jassal DS， Perez-Sanz TM， et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury ［J］. Eur Heart J， 2006， 27（15）: 1868-1875.
|
| 21 |
邢长洋， 袁丽君， 张宇新， 等. 欧洲心血管影像协会/美国超声心动图学会《二维斑点追踪超声心动图应用于左心房及右心应变成像的规范化共识》解读 ［J/OL］. 中华医学超声杂志（电子版），2021， 18（12）: 1135-1139.
|
| 22 |
Liu F， Wang X， Liu D， et al. Frequency and risk factors of impaired left ventricular global longitudinal strain in patients with end-stage renal disease: a two-dimensional speckle-tracking echocardiographic study ［J］. Quant Imaging Med Surg， 2021， 11（6）: 2397-2405.
|
| 23 |
de Almeida AL， Silva VA， de Souza Filho AT， et al. Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline ［J］. Arq Bras Cardiol， 2015， 104（4）: 274-283.
|
| 24 |
Mor-Avi V， Lang RM， Badano LP， et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography ［J］.Eur J Echocardiogr， 2011， 12（3）: 167-205.
|
| 25 |
董文娟， 杨卓璇， 李瑛琪， 等. 三维超声心肌应变参数对慢性心力衰竭左心室重构的预测价值 ［J］. 中国临床医学影像杂志， 2024，35（4）: 246-249.
|
| 26 |
Yu HK， Yu W， Cheuk DK， et al. New three-dimensional speckletracking echocardiography identifies global impairment of left ventricular mechanics with a high sensitivity in childhood cancer survivors ［J］. J Am Soc Echocardiogr， 2013， 26（8）: 846-852.
|
| 27 |
Santoro C， Arpino G， Esposito R， et al. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients:a balance with feasibility ［J］. Eur Heart J Cardiovasc Imaging， 2017，18（8）: 930-936.
|
| 28 |
Liang S， Liu M， Liu Z， et al. Global longitudinal strain assessment in contrast-enhanced echocardiography in breast cancer patients: a feasibility study ［J］. Cardiovasc Ultrasound， 2023， 21（1）: 7.
|
| 29 |
Sanadgol G， Samimi S， Shirini D， et al. Right ventricle toxicity in cancer treatment: a focused review on cardiac imaging ［J］. Future Cardiol， 2023， 19（11）: 537-545.
|
| 30 |
Prinzen FW， Lumens J. Investigating myocardial work as a CRT response predictor is not a waste of work ［J］. Eur Heart J， 2020，41（39）: 3824-3826.
|
| 31 |
Li X， Wang C， Kang R， et al. Evaluating the effect of PD-1 inhibitors on left ventricular function in lung cancer with noninvasive myocardial work ［J］. Quant Imaging Med Surg， 2023， 13（5）: 3241-3254.
|
| 32 |
张铭轩， 李晓东， 张艳丽， 等. 左室压力应变环联合三维斑点追踪技术评价不同年龄段乳腺癌患者化疗后的左室收缩功能 ［J］. 中国临床医学影像杂志， 2023， 34（8）: 549-554.
|
| 33 |
Picano E， Pierard L， Peteiro J， et al. The clinical use of stress echocardiography in chronic coronary syndromes and beyond coronary artery disease: a clinical consensus statement from the European Association of Cardiovascular Imaging of the ESC ［J］. Eur Heart J Cardiovasc Imaging， 2024， 25（2）: e65-e90.
|
| 34 |
Civelli M， Cardinale D， Martinoni A， et al. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity ［J］. Int J Cardiol， 2006， 111（1）: 120-126.
|
| 35 |
Wang S， Wang Y， Wang S. The role of stress echocardiography in identifying cardiotoxicity: an in-depth exploration ［J］. Front Cardiovasc Med， 2024， 11: 1236966.
|
| 36 |
Caenen A， Bézy S， Pernot M， et al. Ultrasound shear wave elastography in cardiology ［J］. JACC Cardiovasc Imaging， 2024，17（3）:314-329.
|
| 37 |
Caenen A， Pernot M， Nightingale KR， et al. Assessing cardiac stiffness using ultrasound shear wave elastography ［J］. Phys Med Biol， 2022，67（2）.
|
| 38 |
Villemain O， Correia M， Mousseaux E， et al. Myocardial stiffness evaluation using noninvasive shear wave imaging in healthy and hypertrophic cardiomyopathic adults ［J］. ACC Cardiovasc Imaging，2019， 12（7 Pt 1）: 1135-1145.
|
| 39 |
朱天刚， 靳文英， 张梅， 等. 心脏超声增强剂临床应用规范专家共识 ［J/CD］. 中华医学超声杂志（电子版）， 2019， 16（10）: 731-734.
|
| 40 |
Liu Z， Liu M， Zhong X， et al. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer ［J］. Cancer Med， 2023， 12（12）: 13374-13387.
|
| 41 |
Dietrich CF， Bolondi L， Duck F， et al. History of ultrasound in medicine from its birth to date （2022）， on occasion of the 50 years anniversary of EFSUMB. A publication of the European Federation of Societies for Ultrasound In Medicine and Biology （EFSUMB），designed to record the historical development of medical ultrasound ［J］.Med Ultrason， 2022， 24（4）: 434-450.
|
| 42 |
Lyon AR， Dent S， Stanway S， et al. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society ［J］. Eur J Heart Fail， 2020， 22（11）: 1945-1960.
|
| 43 |
Battisti NML， Andres MS， Lee KA， et al. Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer ［J］. Breast Cancer Res Treat， 2021， 188（1）: 149-163.
|
| 44 |
McDonagh TA， Metra M， Adamo M， et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure ［J］. Eur Heart J， 2021， 42（36）: 3599-3726.
|
| 45 |
Musella F， Librera M， Sibilio G， et al. Cardiovascular magnetic resonance parametric techniques to characterize myocardial effects of anthracycline therapy in adults with normal left ventricular ejection fraction: a systematic review and meta-analysis ［J］. Curr Probl Cardiol，2024， 49（7）: 102609.
|
| 46 |
Chaganti BT， Negishi K， Okajima K. Role of myocardial strain imaging in cancer therapy-related cardiac dysfunction ［J］. Curr Cardiol Rep， 2022， 24（6）: 739-748.
|
| 47 |
Cronin M， Seher M， Arsang-Jang S， et al. Multimodal imaging of cancer therapy-related cardiac dysfunction in breast cancer-a state-ofthe-art review ［J］. J Clin Med， 2023， 12（19）: 6295.
|
| 48 |
Lyman GH， Kuderer NM. Artificial intelligence and cancer clinical research: III risk prediction models for febrile neutropenia in patients receiving cancer chemotherapy ［J］. Cancer Invest， 2024， 42（7）: 539-543.
|